Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

December 1, 2021; Volume 62,Issue Supplement 3
  • You have access
    Radiopharmaceutical Dosimetry for Cancer Therapy: From Theory to Practice
    Richard L. Wahl and John Sunderland
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 1S-2S; DOI: https://doi.org/10.2967/jnumed.121.263273
  • You have access
    Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
    Jacek Capala, Stephen A. Graves, Aaron Scott, George Sgouros, Sara St. James, Pat Zanzonico and Brian E. Zimmerman
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 3S-11S; DOI: https://doi.org/10.2967/jnumed.121.262749
  • You have access
    Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
    George Sgouros, Yuni K. Dewaraja, Freddy Escorcia, Stephen A. Graves, Thomas A. Hope, Amir Iravani, Neeta Pandit-Taskar, Babak Saboury, Sara St. James and Pat B. Zanzonico
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 12S-22S; DOI: https://doi.org/10.2967/jnumed.121.262750
  • You have access
    Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
    Richard L. Wahl, George Sgouros, Amir Iravani, Heather Jacene, Daniel Pryma, Babak Saboury, Jacek Capala and Stephen A. Graves
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 23S-35S; DOI: https://doi.org/10.2967/jnumed.121.262751
  • You have access
    An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 1: Design and Early Results of the SNMMI Dosimetry Challenge
    Carlos Uribe, Avery Peterson, Benjamin Van, Roberto Fedrigo, Jake Carlson, John Sunderland, Eric Frey and Yuni K Dewaraja
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 36S-47S; DOI: https://doi.org/10.2967/jnumed.121.262748
  • You have access
    Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
    Stephen A. Graves, Alexandru Bageac, James R. Crowley and Denise A.M. Merlino
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 48S-59S; DOI: https://doi.org/10.2967/jnumed.121.262752
  • You have access
    Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice
    Neeta Pandit-Taskar, Amir Iravani, Dan Lee, Heather Jacene, Dan Pryma, Thomas Hope, Babak Saboury, Jacek Capala and Richard L. Wahl
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 60S-72S; DOI: https://doi.org/10.2967/jnumed.121.262977
  • You have access
    Dosimetry for Radiopharmaceutical Therapy: The European Perspective
    Michael Lassmann, Uta Eberlein, Jonathan Gear, Mark Konijnenberg and Jolanta Kunikowska
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 73S-79S; DOI: https://doi.org/10.2967/jnumed.121.262754
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 62 (Supplement 3)
Journal of Nuclear Medicine
Vol. 62, Issue Supplement 3
December 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Radiopharmaceutical Dosimetry for Cancer Therapy: From Theory to Practice
  • Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
  • Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
  • Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
More...
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire